Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

608 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Role of Intersectional Stigma in Coronary Artery Disease Among Cisgender Women Aging with HIV.
Glynn TR, Larson ME, Bernal M, Satish S, O'Reilly CC, Nogueira NF, Zetina AS, Hurtado V, Inestroza K, Kedia S, Vilchez L, Lang B, Valls P, Siegel Y, Schettino C, Ghersin E, Pallikkuth S, Roach M, Pahwa S, Mendez A, Rosa-Cunha I, Hurwitz BE, Potter J, Kanamori M, Duthely LM, Martinez C. Glynn TR, et al. Among authors: kanamori m. Behav Med. 2024 Nov 15:1-12. doi: 10.1080/08964289.2024.2429073. Online ahead of print. Behav Med. 2024. PMID: 39547930
"Test-To-PrEP": Assessing Reach and Adoption of a New Approach to Increase HIV Testing and PrEP Knowledge Using HIV Self-Test Kit Distribution Through PrEP Clients' Social Networks.
Johnson AL, Butts SA, Rodriguez E, Craker L, Kanamori M, Doblecki-Lewis S. Johnson AL, et al. Among authors: kanamori m. J Acquir Immune Defic Syndr. 2023 Dec 15;94(5):421-428. doi: 10.1097/QAI.0000000000003294. J Acquir Immune Defic Syndr. 2023. PMID: 37949445 Free PMC article.
A community-based participatory research approach to the development, refinement, and distribution of Test-to-PrEP: A peer-to-peer distributed at-home HIV self-test and prevention information kit in Miami-Dade, Florida.
Butts S, Rodriguez E, Craker L, Johnson AL, Whiteside P, Blackmon J, Kenya S, Kanamori M, Doblecki-Lewis S. Butts S, et al. Among authors: kanamori m. medRxiv [Preprint]. 2023 Dec 26:2023.12.22.23300158. doi: 10.1101/2023.12.22.23300158. medRxiv. 2023. PMID: 38234743 Free PMC article. Preprint.
CGC1, a new reference genome for Caenorhabditis elegans.
Ichikawa K, Shoura MJ, Artiles KL, Jeong DE, Owa C, Kobayashi H, Suzuki Y, Kanamori M, Toyoshima Y, Iino Y, Rougvie AE, Wahba L, Fire AZ, Schwarz EM, Morishita S. Ichikawa K, et al. Among authors: kanamori m. bioRxiv [Preprint]. 2024 Dec 6:2024.12.04.626850. doi: 10.1101/2024.12.04.626850. bioRxiv. 2024. PMID: 39677790 Free PMC article. Preprint.
Impact of tumor-treating fields on the survival of Japanese patients with newly diagnosed glioblastoma: A multicenter, retrospective cohort study.
Kanamori M, Tsuzuki S, Shibahara I, Saito K, Shimoda Y, Tanaka K, Yamaguchi S, Natsumeda M, Matsutani T, Hanihara M, Nakada M, Kuroda JI, Matsuda M, Yoshimoto K, Yonezawa U, Sonoda Y, Takano K, Yonezawa H, Otani Y, Nakahara Y, Uchida M, Nonaka M, Mineharu Y, Kitamura Y, Yamashita S, Yamauchi T, Miyake Y, Deguchi S, Beppu T, Tamura K, Koizumi S, Hirose Y, Asano K, Hiruta R, Kinoshita M, Miyake K, Nakayama N, Inoue A, Ono T, Sasaki T, Akiyama Y, Fukami S, Yoshino A, Kawanishi Y, Asanome T, Yamaguchi T, Takahashi M, Yamasaki F, Arakawa Y, Narita Y. Kanamori M, et al. Neurooncol Adv. 2024 Nov 28;6(1):vdae176. doi: 10.1093/noajnl/vdae176. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39659832 Free PMC article.
Image-based Re-evaluation of the JCOG0911 Study Focusing on Tumor Volume and Survival, Disease Progression Diagnosis, and Radiomic Prognostication for Newly Diagnosed Glioblastoma.
Kinoshita M, Fushimi Y, Masumoto T, Sasaki K, Sekita T, Natsume A, Wakabashi T, Komori T, Tsuzuki S, Muragaki Y, Motomura K, Saito R, Sato K, Beppu T, Takahashi M, Kuroda JI, Sonoda Y, Kobayashi K, Mishima K, Mitsuya K, Yamasaki F, Inoue A, Matsutani T, Nakamura H, Yamaguchi S, Ishikawa E, Nakaya M, Tanaka S, Ujifuku K, Uchida H, Kanamori M, Otani R, Kijima N, Nishida N, Yoshino A, Mineharu Y, Arakawa Y, Fukuda H, Narita Y; Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG). Kinoshita M, et al. Among authors: kanamori m. Magn Reson Med Sci. 2024 Nov 19. doi: 10.2463/mrms.mp.2024-0103. Online ahead of print. Magn Reson Med Sci. 2024. PMID: 39567017 Free article.
Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection.
Kanamori M, Shibahara I, Shimoda Y, Akiyama Y, Beppu T, Ohba S, Enomoto T, Ono T, Mitobe Y, Hanihara M, Mineharu Y, Ishida J, Asano K, Yoshida Y, Natsumeda M, Nomura S, Abe T, Yonezawa H, Katakura R, Shibui S, Kuroiwa T, Suzuki H, Takei H, Matsushita H, Saito R, Arakawa Y, Sonoda Y, Hirose Y, Kumabe T, Yamaguchi T, Endo H, Tominaga T. Kanamori M, et al. Int J Clin Oncol. 2024 Nov 11. doi: 10.1007/s10147-024-02650-9. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39527165
608 results